UBS Oncology Impact Fund
Europe, Zurich, Switzerland, Zürich
Description
UBS Oncology Impact Fund
Investor Profile
UBS Oncology Impact Fund has backed more than 5 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 20% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B rounds (top funding stages).
- Majority of deals are located in United States, Canada.
- Strong thematic focus on Biotechnology, Oncology, Therapeutics.
Stage Focus
- Series A (60%)
- Series B (40%)
Country Focus
- United States (60%)
- Canada (40%)
Industry Focus
- Biotechnology
- Oncology
- Therapeutics
- Health Care
- Pharmaceutical
- Medical
- Alternative Medicine
- Information Technology
- Biopharma
- Medical Device
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does UBS Oncology Impact Fund frequently co-invest with?
Which angels does UBS Oncology Impact Fund often collaborate with?
What are some of recent deals done by UBS Oncology Impact Fund?
Find More Investors Like UBS Oncology Impact Fund
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides








